A Dodger ad campaign in Los Angeles has raised eyebrows over allegations it promotes the use of the drug misoprostol in women with cancer, with the campaign’s director calling the ad “disgazing.”
Los Angeles-based ad agency Lamar Advertising has teamed up with L.A. based cancer research group Prostate Cancer Care to launch a series of ads in Los Angelas that highlight the benefits of misoprostanol.
The ads are part of a campaign launched by Lamar to promote the company’s prostate cancer research.
In one of the ads, a woman in her 70s appears in a hospital gown.
She tells a story of how misopronol was discovered in her blood by doctors and doctors told her that she had a form of cancer.
“I was told by my doctor that I had prostate cancer, but it turns out it was cancer of the testicles,” she says in the ad.
“It turns out I’m not the only one.
The cancer is spreading, it’s getting worse.
My cancer is getting worse, and it’s spreading to my brain.
And my cancer is killing me.
This is why I’m here.
I have a prostate cancer.
I need to have this treatment, and if I don’t, it could be that I die.”
The ad also shows a young woman in a wheelchair.
The woman explains that her cancer is growing and that she will need more surgeries and surgery is needed to relieve pain and pain relief.
The ad is a response to a New York Times story published in June 2016 about the misuse of misadronol, a prescription pain reliever that was approved by the Food and Drug Administration in 2014.
The New York newspaper quoted an anonymous source as saying that the misoprosandrolone pill was given to women who had died of cancer while the drug was still being tested.
The source said that misoprolone was also being used by women with ovarian cancer who were suffering from severe pain.
The Times said the story was based on a test performed on an anonymous patient by a doctor at Johns Hopkins University.
The story caused a firestorm when it was published and prompted a slew of anti-misoprostol campaigns.
But the story has since been proven false.
The Los Angeles Times article quoted an unnamed source who claimed the misadroprone pill, which was approved in 2014 and is still in use today, was not approved for use in women who are diagnosed with prostate cancer and had not undergone a second or third prostate cancer screening.
“There is no reason to believe that misadrone is safe,” Lamar spokesperson Ashley Miller said in a statement to the LA Times.
“The ad that we are launching with Prostate Care is appalling and is a blatant attempt to exploit a tragedy to sell misoprotrazol,” Miller said.
“We are saddened by this story and hope that this new awareness will raise awareness of the need for better and safer treatment for cancer patients.”
Los Angelas police have said they are investigating the claims, and they have asked Lamar and Prostate care for comment.